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Background: Consumption of medicinal plants to overcome diseases is traditionally belongs to the characteristics
of most cultures on this earth. Sudan has been a host and cradle to various ancient civilizations and developed a
vast knowledge on traditional medicinal plants. The present study was undertaken to evaluate the antioxidant,
antiangiogenic and cytotoxic activities of six Sudanese medicinal plants which have been traditionally used to treat
neoplasia. Further the biological activities were correlated with phytochemical contents of the plant extracts.
Methods: Different parts of the plants were subjected to sequential extraction method. Cytotoxicity of the extracts
was determined by dimethylthiazol-2-yl)- 2,5diphenyl tetrazolium bromide (MTT) assay on 2 human cancer (colon
and breast) and normal (endothelial and colon fibroblast) cells. Anti-angiogenic potential was tested using ex vivo
rat aortic ring assay. DPPH (1,1-diphenyl-2-picrylhydrazyl) assay was conducted to screen the antioxidant capabilities of
the extracts. Finally, total phenolic and flavonoid contents were estimated in the extracts using colorimetric assays.
Results: The results indicated that out of 6 plants tested, 4 plants (Nicotiana glauca, Tephrosia apollinea,
Combretum hartmannianum and Tamarix nilotica) exhibited remarkable anti-angiogenic activity by inhibiting the
sprouting of microvessels more than 60%. However, the most potent antiangiogenic effect was recorded by
ethanol extract of T. apollinea (94.62%). In addition, the plants exhibited significant antiproliferative effects against
human breast (MCF-7) and colon (HCT 116) cancer cells while being non-cytotoxic to the tested normal cells. The
IC50 values determined for C. hartmannianum, N. gluaca and T. apollinea against MCF-7 cells were 8.48, 10.78 and
29.36 μg/ml, respectively. Whereas, the IC50 values estimated for N. gluaca, T. apollinea and C. hartmannianum
against HCT 116 cells were 5.4, 20.2 and 27.2 μg/ml, respectively. These results were more or less equal to the
standard reference drugs, tamoxifen (IC50 = 6.67 μg/ml) and 5-fluorouracil (IC50 = 3.9 μg/ml) tested against MCF-7
and HCT 116, respectively. Extracts of C. hartmannianum bark and N. glauca leaves demonstrated potent antioxidant
effect with IC50s range from 9.4–22.4 and 13.4–30 μg/ml, respectively. Extracts of N. glauca leaves and T apollinea aerial
parts demonstrated high amount of flavonoids range from 57.6–88.1 and 10.7–78 mg quercetin equivalent/g,
respectively.
Conclusions: These results are in good agreement with the ethnobotanical uses of the plants (N. glauca, T. apollinea,
C. hartmannianum and T. nilotica) to cure the oxidative stress and paraneoplastic symptoms caused by the cancer.
These findings endorse further investigations on these plants to determine the active principles and their mode of action.
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Cancer is a major public health burden in both developed
and developing countries. The International Agency for
Research on Cancer (IARC), the specialized cancer agency
of the World Health Organization reported that about
14.9 million cancer cases were estimated around the world
in 2013, of these 7.7 million cases were in men and 6.9
million in women and further this number is expected to
increase to 24 million by 2035 [1]. Treating cancer has be-
come a major challenge as there is no single effective
treatment that works for all types of cancer. Most of con-
ventional chemotherapy regimens which employ different
combinations of cytotoxic drugs which are often associ-
ated with serious side effects and chemoresistance. Con-
ventional therapy has also become less favorable in the
mindset of sufferers and as a result many patients resort
to seeking alternative treatments [2]. The resistance of
metastatic cancerous cells to chemotherapy and its ad-
verse effects has become a serious challenge in cancer
research. Despite the intensive progress in chemothera-
peutics in the last decades, the need to discover and to
develop new, alternative, or adjuvant therapeutic agents
remains.
Botanicals have long been used traditionally in treatment
of various types of cancers [3] and often less associated
with the side effects like the modern chemotherapy has [4].
Realizing the potential benefits of botanicals as a source
of active anticancer compounds, the National Cancer
Institute (U.S.A) collected about 35,000 plant samples
from 20 countries and has screened around 114,000
extracts for anticancer activity [5]. Out of the 92 anti-
cancer drugs marketed prior to 1983 in US and among
the ones sold worldwide between 1983 and 1994, 60%
are of natural origin [6]. This includes natural products,
derivatives of natural products or semi-synthetic phar-
maceuticals based on natural products models [7].
Angiogenesis is the sprouting of new blood vessels
from pre-existing vessels and is strongly implicated in
solid tumorgenesis, proliferative retinopathies, obesity
and rheumatoid arthritis [8]. Tumor angiogenesis is the
consequence of an angiogenic imbalance in which pro-
angiogenic factors predominate over antiangiogenic factors.
Furthermore, angiogenesis is essential for growth and
metastasis of malignant tumors. Vascular Endothelial
Growth Factor-A (VEGF-A) is believed to be a critical
angiogenic mitogen [9]. Therefore, tumor angiogenesis can
be considered as an important pharmacological target for
cancer prevention and treatment [10,11]. Consequently,
this hypothesis has paved a pathway for the development of
the cutting edge therapeutic technology called angiother-
apy. Anti-angiogenic approach can overcome the cytotoxic
adverse effects and chemoresistant problems associated
with the classical chemotherapies. Anti-angiognenic drugs
work by inhibiting the synthesis of new blood vessels thatsupply blood, nutrients and oxygen to growing tumor.
Previous reports of Avastin, a monoclonal antibody for
VEGF, and fluorouracil-based combination therapy showed
a significant improvement in survival of patients with
metastatic colorectal carcinoma [12]. However conven-
tional antiangiogenic compounds based on monoclonal
antibody technology may have limitations from the cost
point of view. Plant sources of antiangiogenic compounds
have been explored as they are more economical to pro-
duce in large scale [13]. However at present there are no
plant based antiangiogenic compounds available commer-
cially in the market.
Plants have many phytochemicals which are potential
source of natural antioxidants, such as phenolic diter-
penes, flavonoids, tannins and polyphenolic acids [14]
with versatile biological activities. Plant polyphenolics
have been recognized as the potential therapeutic agents
targeting cancer, pathological angiogenesis and cardio-
vascular disease in the next decade [15,16]. These bene-
fits have been attributed to the presence of antioxidant-
rich polyphenolic compounds [16,17].
The use of traditional medicine especially medicinal
plants in Sudan is still the main alternative therapy which
is based entirely on the indigenous knowledge gained from
ancestral experience. Although, there is an important local
ethno botanical biography describing the most frequently
used plants in treatment of various clinical conditions
however, very few have been studied scientifically for
chemometric analysis of the medicinal herbs to identify
the active principles. The vast majority is still unexplored
phytochemically and their medicinal properties have not
yet validated [18].
Compelling data implicate angiogenesis and tumor-
associated neovascularization as a central pathogenic step
in the process of tumor growth, invasion and metastasis.
Subsequently, it was shown that a significant correlation
existed between the degree of tumor angiogenesis (micro
vessel density) and survival in patients presenting with
lymph node-negative breast carcinoma [19]. Therefore, it
comes to handy that targeting tumor angiogenesis using
antiangiogenic agents the blood vessels which supply the
tumor with nutrients and oxygen, in turn it could lead to
halt tumor growth and metastasis.
With this background, the present study was under-
taken to analyze the antiangiogenic, antioxidant and
cytotoxic properties of 32 extracts prepared from six
Sudanese plants; Indigofera spinosa Forsk. (Leguminosae),
Nicotiana glauca var. (Solanaceae), Tephrosia apollinea
(Del.) Link (Leguminosae), Tamarix nilotica (Ehrenb.)
Bunge (Tamaricaceae), Combretum hartmannianum
Schweinf. (Combretaceae) and Capparis decidua (Forsk.)
Edgew (Capparaceae). This study is the first to report the
antiangiogenic properties of these selected Sudanese medi-
cinal plants and correlated the activity with antioxidant
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of the extracts was conducted to identify the potential
source of antineoplastic agents.
Methods
Plant material
Six Sudanese medicinal plants, I. spinosa, N. glauca, T.
apollinea, T. nilotica, C. hartmannianum and C. decidua
were selected for the study. Plant material was collected
during the period of March-July 2013 except C. hartmaniu-
num which was collected during March 2014 from
Elgadarif City – Sudan. The taxonomic authentication of all
the plants was carried out at The Medicinal and Aromatic
Plants Research Institute, National Center for Research by
Dr. Wail Alsadig. Voucher specimens (voucher references
numbers: MAPRI/NB-53a-g) were deposited at the herbar-
ium of the institute.Preparation of extracts
The plant materials were dried in oven (35–40°C) and
powdered mechanically. The pulverized plant material
(50 g) was subjected to sequential extraction method
started with n-hexane and followed by ethanol, methanol
and water. All the extracts were prepared by 250 ml of
the solvents using hot maceration (40°C) method with
intermittent shaking. The extracts were filtered and con-
centrated at 45°C under vacuum by rotary evaporator
(Buchi, USA) and further dried overnight at 45°C. Stock
solutions of the extracts were prepared at 10 mg/ml in
100% dimethyl sulfoxide (DMSO). Further serial dilution
of the stock was performed with cell culture media to
obtain a range of desired concentrations of the extracts.
All solvents used in this study were of analytical grade.Experimental animals
Twelve to fourteen weeks old healthy Sprague Dawley
male rats were used. To avoid physiological variations that
could affect the process of angiogenesis in female rats due
to estrous cycle, only male rats were used in rat aortic ring
assay. The animals obtained from animal house facility of
Universiti Sains Malaysia (USM) and were kept for one
week in animal transit house (School of Pharmaceutical
Sciences, USM) prior to the experiments. The animals
were kept in well ventilated cage with food and water
provided. The animals were euthanized using CO2 and
dissected to excise thoracic aorta. All procedures were
carried out according to the guidelines of Animal Ethics
Committee USM. The present study was submitted to the
institutional animal ethics committee, “Animal Ethics
Committee USM” for evaluation and the present study is
approved by the committee (approval Reference number:
PPSG/07 (A)/044/(2010) (61)).Chemicals and reagents
Cell culture reagents were purchased from Gibco, USA;
RPMI 1640 medium; catalogue number (A10491-01),
Dulbecco’s Modified Eagle Medium; Catalogue number
(31100–035) were obtained from GIBCO, UK. Phosphate
buffered saline, trypsin, heat inactivated foetal bovine
serum (HIFBS), penicillin/streptomycin (PS), fibrinogen,
aprotinin, thrombin, suramin, aprotinin, 6-Aminocaproic
acid, L-glutamine, thrombin and gentamicin were purchased
from Sigma, Germany. MTT (3-(4,5-Dimethylthiazol-2-yl)-
2,5diphenyl tetrazolium bromide) was procured from
Sigma-Aldrich, USA. Dimethyl sulfoxide (DMSO) was pur-
chased from Fluka, USA.
Cell lines and culture conditions
Human Umbilical Vein Endothelial Cell line HUVEC
(Passage No. 3), catalogue number (C2517A); human colo-
rectal carcinoma cell line HCT-116 (Passage No. 5), cata-
logue number (CCL-247); human hormone sensitive and
invasive breast cancer cell line MCF-7 (Passage No. 4),
catalogue number (HTB-22); human colorectal normal cell
line CCD-18 (Passage No. 3), catalogue (CRL-1459) were
purchased from ScienCell, USA. HUVEC were maintained
in endothelial cell medium (ECM) (ScienCell, USA) supple-
mented with endothelial cell growth supplements (ECGS),
5% HIFBS and 1% PS. HCT-116 cells were maintained in
RPMI whereas, MCF-7 and CCD-18Co were maintained in
DMEM medium. The media were supplemented with 5%
heat inactivated fetal bovine serum and 1% penicillin/
streptomycin. Cells were cultured in a humidified incuba-
tor at 37°C supplied by 5% CO2. Cell culture work was
done in sterile conditions using Class II biosafety cabinet
(ESCO, USA).
Rat aorta ring assay
This assay was carried out on rat aortic explants as previ-
ously described [20]. Thoracic aortas were removed from
euthanized male rats, rinsed with serum free medium and
cleaned from fibroadipose tissues. Totally 18 rats were
used in this assay and approximately 12 to 14 rings (each
ring is about 1 mm thickness) were prepared from an each
aorta. The aortas were cross sectioned into small rings
and seeded individually in 48-wells plate in 300 μL serum
free M199 media containing 3 mg/ml fibrinogen and
5 mg/ml aprotinin. Ten microliters of thrombin (50 NIH
U/ml in 1% bovine serum albumin in 0.15 M NaCl) was
added into each well and incubated at 37°C for 90 min to
solidify. A second layer (M 199 medium supplemented
with 20% HIFBS, 0.1% έ-aminocaproic acid, 1% L-Glutam-
ine, 2.5 μg/ml amphotericin B, and 60 μg/ml gentamicin)
was added into each well (300 μL/well). All the extracts
were added at final concentrations of 100 μg/ml. Suramin
and 1% DMSO were used as positive and negative con-
trols, respectively. On day four, the medium was replaced
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aortic rings were photographed using EVOS f1 digital
microscope (Advanced Microscopy Group, USA) (40×
magnification) and subsequently the length of blood
vessels outgrowth from the primary tissue explants was
measured using Leica Quin software.
The inhibition of blood vessels formation was calcu-
lated using the formula;
% blood vessels inhibition = [1- (A0/A)] × 100, Where;
A0 = distance of blood vessels growth in treated rings in
μm, A = distance of blood vessels growth in the control
in μm.
The results are presented as mean percent inhibition ±
SEM, (n =8).
The significant difference between the microvessels
out growth in treated versus untreated aortic rings was
calculated using Student’s t test. Based on the results of
this assay, TAF273 was chosen for the subsequent inves-
tigations for the anti-angiogenic property.
Cytotoxicity assay
The MTT cytotoxicity assay was performed according to
the method previously described [21]. Cells were seeded
at 1.5 × 104 cells in each well of 96-well plate in 100 μl
of fresh culture medium and were allowed to attach for
overnight. For screening, the cells (70 - 80% confluency)
were treated with the extracts at the final concentra-
tion of 50 μg/ml. Later on, in order to obtain a dose–
response curve, the most active extracts were tested
for cytotoxicity at 3.12, 6.25, 12.5, 25, 50 and 100 μg/ml
concentrations. After 48 h of the treatment the medium
was aspirated and the cells were exposed to MTT solu-
tion prepared at 5 mg/ml in sterile PBS was added to
each well at 10% v/v in the respective medium and was
incubated at 37°C in 5% CO2 for 3 h. The water insoluble
formazan salt was solubilized with 200 μl DSMO/well.
Absorbance was measured by infinite® Pro200 TECAN
Group Ltd., (Switzerland) at primary wave length of
570 nm and reference wavelength of 620 nm. Each plate
contained the samples, negative control and blank. DMSO
(1% v/v) was used as a negative control. 5-fluorouracil,
Tamoxifen and Betulinic acid were used as standard
reference control for HCT 116, MCF-7 and CCD-18Co
cell lines, respectively. The assay was performed in quadri-
cate and the results were presented as a mean percent
inhibition to the negative control ± SEM.
Determination of total phenols
Total phenols in the extracts were determined by a colori-
metric method as described by Al-Suede and co-workers
[22]. A stock of 1 mg/ml of extracts was prepared in
methanol and 100 μl of each extract was added separately
to 750 μl of Folin-Ciocalteau phenol reagent (1:10 diluted
with double distilled H2O). After 5 min incubation in thedark at room temperature, 750 μl sodium bicarbonate
solution (60 g/l) was added and incubated at 30°C in the
dark for 90 min. The absorbance was measured at 725 nm
using TECAN Multi-mode microplate reader Model
Infinite® 200 (Mannedorf, Switzerland). Gallic acid was
used (5–80 μg/ml) to construct the standard calibration
curve. The results were expressed as Gallic acid equivalents
per 100 mg of extract (mg GAE/100 mg).
Determination of total flavonoids
The total flavonoids content in the extracts was deter-
mined using aluminum chloride colorimetric method
with quercetin as standard [23]. A solution of 4 mg/ml
of quercetin in methanol was prepared. Exactly, 500 μl
of different concentrations (3 to 200 μg/ml) of the
extracts were taken in separate test tubes. To each of the
test tubes, 0.1 ml of 10% (w/v) aluminum chloride solu-
tion, 0.1 ml of 1 M potassium acetate solution, 1.5 ml of
methanol and 2.8 ml of distilled water was added. The test
tubes were thoroughly mixed and after incubation at room
temperature for 30 min, the absorbance reading of the
reaction mixture was measured at 415 nm using a spectro-
photometer (Perkin Lambda 45). A standard curve plotting
all the different concentrations of quercetin standard was
constructed and the total flavonoid content is expressed as
micrograms of quercetin equivalent. The data were
presented as mean ± SEM (n =6).
DPPH scavenging effect
DPPH (1,1-diphenyl-2-picrylhydrazyl) assay was carried
out to evaluate the scavenging activity of the extracts
[24]. The stock solution of DPPH was prepared at a
concentration of 200 μM in absolute methanol while
stock solutions of the extracts were prepared at concen-
tration of 10 mg/ml. DPPH was dispensed into 96-well
plate (100 μl/well) and immediately, 100 μl of test samples
were added at final concentrations of 12.5, 25, 50, 100,
200 μg/ml. Methanol alone and methanol with DPPH
were used as blank and negative control, respectively.
Ascorbic acid was used as positive control. The mixtures
were incubated at 30°C for 30 min in the dark and then
the absorbance was measured at 517 nm using TECAN
microplate reader Model Infinite® 200 (Mannedorf,
Switzerland). The dose response curves were obtained and
then used to calculate the median inhibitory concentration
(IC50). The results are expressed as mean ± SEM (n =6).
Results
Plant extraction
Four exacts were prepared from each plant material,
starting with n-hexane followed by ethanol, methanol
and water. The yield of each extract was calculated and
presented in Table 1 as w/w percent yield. Among all
the extracts, hexane extracts of all the tested plants
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tract (7.8%). On average, the ethanol extracts of the tested
plants showed the highest yield followed by methanol and
water extracts. For instance, the highest yield recorded
was 15.68% for ethanol extract of C. hartmannianum
leaves. Table 1 shows the list of plants and the parts used
in this study.
Inhibitory effect of the extracts on sprouting of
microvessels in rat aortic explants
This assay was performed as the primary assay to screen
the antiangiogenic potential of the extracts. Figure 1Ashows a massive sprouting of microvessels in the aortic
explants of vehicle treated group (negative control).
Plant extracts with more than 60% inhibition of sprout-
ing of blood vessels were considered as active extracts.
Table 2 depicts the antiangiogenic properties of plant ex-
tracts determined by rat aorta ring assay. Out of 32 ex-
tracts, 12 extracts from three plants namely T. apollinea,
C. hartmannianum and T. nilotica showed potent (more
than 60%) inhibitory activity. The highest inhibition
(100%) was produced by ethanol extract of aerial parts
of T. apollinea (Figure 1B), followed by water extracts of
T. nilotica (Figure 1C). Interestingly, all the extracts of
C. hartmannianum (Figure 1D) stem bark displayed sig-
nificant (p <0.05) inhibition of micro-blood vessels with
an order of ethanol (88.74%) followed by menthol
(86.68%) and n-hexane (81.75%). Moreover, methanol and
ethanol extracts of C. hartmannianum leaves also demon-
strated significant (p <0.01 and p <0.05, respectively) anti-
angiogenic effect with 68.84 and 63.68%, respectively. In
addition, Figure 1E depicted the remarkable inhibitory
effect on microvessel growth from the rat aortic explant
treated with T. nilotica extract. These results were very
much comparable with the positive control, suramin
which demonstrated potent inhibition of microvessel
growth (Figure 1F). Figure 1G graphically depicts the
difference between the effects of the extracts and Suramin.
Anti-proliferative effect of the extracts against
cancer cells
The MTT assay was used to screen the possible cyto-
toxic activity of 32 extracts against two human cancer
cells lines (HCT-116 and MCF-7) and two normal cell
lines (HUVEC and CCD-18Co). For screening, the cells
were treated with the extracts at 50 μg/ml concentration.
The extracts with more than 60% inhibition of cell pro-
liferation were considered as active extracts. Hexane ex-
tracts of N. glauca leaves and stem exhibited the highest
cytotoxicity on all the tested cell lines, while hexane and
ethanol extracts of aerial part of T. apollinea showed se-
lective antiproliferative effect against breast cancer cell line
(MCF-7) with 87.20 and 86.94%, respectively. The hexane
extract of C. hartmannianum leaves potently inhibited the
growth of both cancer cell lines (HCT-116 and MCF-7)
with 80.03 and 95.76% anti-proliferative effect, respect-
ively. Moreover, the ethanol extract of C. hartmannianum
stem bark showed selective cytotoxicity towards MCF-7
with 76.79%. Interestingly, all the extracts of C. hartman-
nianum showed poor cytotoxicity against the normal cell
lines (Table 3). Further, the most active extracts were
selected to study the dose response cytotoxic effect. The
median inhibitory concentration (IC50) values for the most
active extracts and the respective standard reference drugs
were calculated for all the tested cell lines and the values
are given in Table 4.
Figure 1 Antiangiogenic effect of selected Sudanese plants (100 μg/ml) against sprouting of microvessels in rat aortic explants.
A) Photomicrographic image of rat aortic ring of negative control showing extensive growth of microvessels. B) Photomicrographic image of rat
aortic ring representative of polar extract of T. apollinea displaying potent inhibition of growth of microvessels. C) Treatment with T. nilotica
showed significant inhibitory effect against sprouting of microvessels from rat aortic rings. D) Photomicrographic image of rat aortic explant
treated with C. hartmannianum extract demonstrated considerable effect of antiangiogenicity. E) Photomicrographic image of rat aortic explant
treated with non-polar extract of T. apollinea showing significant inhibitory effect on growth of microvessels. F) Photomicrographic image of rat
aortic explant treated with standard reference, suramin exhibiting strong inhibitory effect on microvessels growth. G) Graphical representation of
antiangiogenic activity of the active extracts obtained from the selected Sudanese plants. The values are expressed as mean ± SEM (n =10).
**p < 0.01 and *p < 0.05 compared to negative control group (0.1% DMSO).
Table 2 Antiangiogenic activity of the selected Sudanese
plants on rat aortic explants
Botanic namen Part used Extract Inhibition (%)
Tephrosia apollinea Aerial parts Ethanol 94.6 ± 1.8**
Tamarix nilotica Leaves Water 91.7 ± 2.2**
Combretum hartmannianum Bark Ethanol 88.7 ± 1.6*
Combretum hartmannianum Bark Methanol 86.6 ± 3.8**
Combretum hartmannianum Leaves n-hexane 81.7 ± 1.7*
Tephrosia apollinea Aerial part Methanol 79.8 ± 2.6*
Tephrosia apollinea Aerial parts n-hexane 73.1 ± 1.5*
Combretum hartmannianum Bark Water 71.5 ± 5.3*
Tamarix nilotica Leaves Methanol 65.5 ± 2.9*
Combretum hartmannianum Leaves Methanol 68.8 ± 2.2*
Combretum hartmannianum Leaves Ethanol 63.6 ± 1.4*
Results are presented as mean percent inhibition ± S.D, n = 3.
Statistical significance is expressed as * = P <0.05, ** = P <0.01.
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ard reference drugs, 5-fluorouracil, betulinic acid and tam-
oxifen. Figures 2A and B show the graphical illustration of
the dose-dependent antiproliferative effect of the active
extracts against human HCT 116 and MCF-7 cell lines.
Figure 3 shows the photomicrographic images of the
treated HCT 116, MCF-7, CCD-18Co and HUVEC cell
lines. The morphological feature of the treated cancer cells
presented clear evidence of strong cytotoxicity of the
extracts, as the vehicle (1% DMSO) treated cells displayed
a compact monolayer of aggressively growing cancer cells
with prominent nuclei and intact cell membrane. Whereas
the images taken from the extracts treated group showed
a drastic reduction in the number of cells because of the
anti-proliferative activity of the extracts. In addition, the
extracts severely affected the pseudopodial projections of
the cells which rendered the cells non-adherent and
Table 3 Cytotoxic effect of different extracts of the selected Sudanese plants
Plants Part used Solvent used % inhibition of cell proliferation
HCT-116 MCF-7 CCD HUVECs
Indgosfera spinosa Stem n-Hexane 27.79 40.43 4.16 5.64
Ethanol 14.98 42.48 5.42 6.08
Methanol 11.16 41.86 4.93 6.79
Water 12.95 33.90 6.18 8.11
Nicotiana gluaca Leaves n-Hexane 95.08 99.38 45.63 62.05
Ethanol 49.66 81.10 38.57 36.25
Methanol 19.83 75.58 10.15 22.64
Water 17.20 49.81 8.09 19.79
Stem n-Hexane 87.07 92.01 44.35 59.46
Ethanol 33.58 49.28 32.63 25.43
Methanol 43.47 53.51 40.47 27.87
Water 28.95 57.53 38.56 19.89
Tephrosia apollinea Aerial part n-Hexane 53.86 87.20 9.65 26.95
Ethanol 46.91 86.94 7.88 16.28
Methanol 47.43 87.09 10.23 18.91
Water 16.86 25.60 4.68 5.79
Tamarix nilotica Leaves n-Hexane 29.33 47.25 8.77 14.58
Ethanol 7.8 46.61 5.83 22.89
Methanol 19.61 46.14 6.65 17.35
Water 6.93 28.47 3.87 11.68
Combretum hartmannianum Leaves n-Hexane 80.03 95.76 7.75 16.62
Ethanol 33.69 54.04 6.35 7.88
Methanol 17.61 78.22 7.79 9.58
Water 26.02 36.30 6.23 5.65
Bark n-Hexane 26.30 42.43 5.74 6.61
Ethanol 29.11 76.79 6.48 8.36
Methanol 13.75 73.64 9.57 11.59
Water 28.40 49.92 10.11 9.47
Capparis decidua Stem n-Hexane 33.78 50.07 5.34 15.45
Ethanol 8.5 41.99 3.69 5.77
Methanol 14.76 39.87 5.58 19.57
Water 21.82 54.41 6.76 4.38
Table 4 IC50 (μg/ml) values of the active extracts of the
selected Sudanese plants
Extracts Carcinoma cell lines Normal cell lines
HCT 116 MCF-7 HUVEC CCD-18CO
C. hartmannianum 27.2 8.48 116.5 466.4
N. gluaca 5.4 10.78 46.2 79.82
T. apollinea 20.2 29.36 98.4 345.6




3.9 6.67 88.4 128.9
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studied showed either mild or negligible cytotoxicity
towards the both normal (HUVEC and CCD-18Co) cell
lines which were used as the model cell lines for the
normal human cells.
Total phenolic contents in the extracts
The amount of total phenolic compounds present in
each extract was determined from linear regression
equation of calibration curve, {y =0.0034 + 0.0144 (R2 =
0.9976) and expressed as Gallic acid equivalent in mg/ml
of extracts. Table 5 depicts the result of assessment of
Figure 2 Dose dependent inhibitory effect of the active extracts of the selected Sudanese plants against HCT 116 (A) and MCF-7
(B) cell lines. The values are expressed as mean ± SEM (n =6).
Hassan et al. BMC Complementary and Alternative Medicine 2014, 14:406 Page 8 of 14
http://www.biomedcentral.com/1472-6882/14/406total phenolic contents in all the tested extracts. It is
found that, hexane extracts of all the plants were de-
prived of total phenolic contents, either no or negligible
amount of phenolic contents were detected in all hexane
extracts. However, the methanol, ethanol and water
extracts of the tested plants showed considerable level of
phenolic contents. The results showed that, both stembark and leaves of C. hartmannianum displayed high
contents of total phenolics in which ethanol, methanol
and water extracts showed 404.05 ± 0.06, 96.56 ± 0.05
and 523.36 ± 0.00 mg GAE/g, respectively for stem bark,
whereas 169.19 ± 0.02, 392.83 ± 0.01, 268.21 ± 0.03 mg
GAE/g, respectively for leaves. The results showed that
methanol and water extracts of T. nilotica also
Figure 3 Photomicrographic images of the cancer (HCT 116 and MCF-7) and normal (HUVEC and CCD-18Co) cell lines taken under an
inverted phase-contrast microscope at × 200 magnification with a digital camera at 48 hours after treatment with the active extracts
of the selected Sudanese plants. The controlled cells showed a fully confluent growth with the compact layer of proliferating cells. Whereas,
treatment with the active extracts caused a drastic reduction in the density of cell-population however, treatment with the extracts did not
produced significant cytotoxicity against the tested normal cells (HUVEC and CCD-18Co) when compared to the negative control group. The
picture revealed that the cells revealed sever morphological changes in their native cellular characteristics. Treatment caused the cells to lose the
psuedopodial like membrane projections. Higher magnification of the photomicrographs revealed several clear features of apoptosis, such as the
membrane blebbing, nuclear condensation and apoptotic bodies in the treated cells.
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with 333.96 ± 0.01 and 171.66 ± 0.02 mg GAE/g, respect-
ively. The leaves extracts of N. glauca showed moderate
level of total phenolic contents (ethanol extract =111.62 ±
0.01 mg GAE/g; methanol extract =139.99 ± 0.01 mg
GAE/g; water extract =105.66 ± 0.01 mg GAE/g).
Total flavonoids contents in the extracts
The total flavonoids contents in each extract were
determined from linear regression equation of calibra-
tion curve obtained from the different concentrations of
quercetin [y = 0.0032 + 0.0669 (R2 = 0.986)] and the re-
sults were expressed as mg quercetin equivalent/g of ex-
tracts (Table 5). Hexane extracts of all the tested plants
and their parts showed higher content of flavonoids
than compared to the other solvent extracts. However,
on average all the extracts demonstrated considerably
high amount of flavonoids in N. glauca leaves withhexane extract =88.150 ± 0.01 mg quercetin equivalent/g,
ethanol extract =77.083 ± 0.00 mg quercetin equivalent/g,
methanol extract =64.583 ±mg quercetin equivalent/g and
water extract =57.667 ±mg quercetin equivalent/g. Ex-
tracts of aerial parts of T. apollinea also showed significant
level of flavonoids with hexane extract =66.950 ± 0.01 mg
quercetin equivalent/g, ethanol extract =78.092 ± 0.00 mg
quercetin equivalent/g, methanol extract =10.708 ± 0.01 mg
quercetin equivalent/g and water extract =23.575 ± 0.02 mg
quercetin equivalent/g. The total flavonoid contents mea-
sured in the extracts is given in the Table 5.
DPPH scavenging effect of the extracts
IC50 values of DPPH scavenging activity of the extracts is
tabulated in Table 5. On average, the extracts prepared
from methanol demonstrated the most potent antioxidant
activity, whereas the extracts prepared from the solvent
hexane displayed poor DPPH scavenging activity as the
Table 5 Correlation between antioxidant activity of different extracts of selected Sudanese plants and the total
content of flavonoids and phenolics in the extracts
Plants Part used Solvent used DPPH (IC50 in μg/ml) Total flavonoids (mg/g) Total phenolics (mg/g)
Indgosfera spinosa Stem n-Hexane >1000 28.1 ± 0.00 ND
Ethanol 192.63 40.2 ± 0.04 115.4 ± 0.01
Methanol 140 36.6 ± 0.01 161.4 ± 0.03
Water >1000 13.3 ± 0.01 78.5 ± 0.001
Nicotiana gluaca Leaves n-Hexane >1000 88.1 ± 0.01 ND
Ethanol 54.76 77.1 ± 0.00 111.6 ± 0.01
Methanol 13.437 64.5 ± 0.002 139.9 ± 0.01
Water 30.05 57.6 ± 0.001 105.6 ± 0.01
Stem n-Hexane >1000 58.6 ± 0.02 3.46 ± 0.01
Ethanol 160.94 13.1 ± 0.01 ND
Methanol 119.45 17.9 ± 0.01 41.02 ± 0.003
Water 591.98 ND 12.5 ± 0.02
Tephrosia apollinea Aerial part n-Hexane >1000 66.9 ± 0.01 ND
Ethanol 120.22 78.1 ± 0.00 ND
Methanol 48.803 10.7 ± 0.01 25.7 ± 0.00
Water 2835.07 23.5 ± 0.02 23.5 ± 0.01
Tamarix nilotica Leaves n-Hexane >1000 67.8 ± 0.00 ND
Ethanol 880.70 13.1 ± 0.04 15.3 ± 0.04
Methanol 12.62 24.9 ± 0.02 333.9 ± 0.01
Water 67.53 22.6 ± 0.001 171.6 ± 0.02
Combretum hartmannianum Leaves n-Hexane >1000 42. ±0.002 ND
Ethanol 146.35 45.2 ± 0.001 169.2 ± 0.02
Methanol 14.067 57.7 ± 0.001 392.8 ± 0.01
Water 967.55 27.6 ± 0.02 268.2 ± 0.03
Bark n-Hexane >1000 42.1 ± 0.01 1.9 ± 0.01
Ethanol 9.47 28.1 ± 0.02 404.1 ± 0.06
Methanol 28.91 24.2 ± 0.02 96.5 ± 0.05
Water 22.47 29.7 ± 0.01 523.3 ± 0.01
Capparis decidua Stem n-Hexane 212.56 67.5 ± 0.02 85.2 ± 0.01
Ethanol 900.58 8.5 ± 0.02 19.9 ± 0.01
Methanol 76.38 4.6 ± 0.02 40.3 ± 0.2
Water >1000 ND 335.7 ± 0.01
ND = Not Detected. The results are presented as mean ± SEM. Each experiment was repeated three times; (n =3).
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Among the tested plants, C. hartmannianum stem bark
exhibited significant (p < 0.01) antioxidant activity as
lowest IC50 values were calculated for ethanol extract
(IC50 = 9.47 μg/ml), methanol extract (IC50 = 28.91 μg/ml)
and water extract (IC50 = 22.47 μg/ml). Similarly, N. glauca
leaves also demonstrated significant (p < 0.05) antioxidant
activity. The IC50 values for ethanol, methanol and water
extracts of N. glauca leaves were calculated as 54.76,
13.437 and 30.05 μg/ml, respectively. The other plants dis-
played either moderate or insignificant DPPH scavenging
activity (Table 5).Discussion
Increasing evidences in both experimental and clinical
studies suggest that angiogenesis and oxidative stress play
a cumulative role in the pathogenesis of malignancy.
Angiogenesis, a process of formation of new blood vessel
from pre-existing vessels, strongly implicates in the meta-
static carcinogenesis. The role of reactive oxygen species
(ROS) in tumorous angiogenesis has been extensively in-
vestigated and various connections have been established
[25]. ROS can function as signaling molecules to mediate
various angiogenic-related responses such as cell prolifera-
tion, differentiations and migration [26,27].
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medicinal systems that have been derived from trad-
itional knowledge and practiced in many countries.
Similarly, many herbal extracts and products are trad-
itionally being used in Sudan for the treatment of can-
cer [28]. However, such medicinal plants have not
gained clinical importance as botanicals due to the lack
of systematic and scientific evidence presented through
the suitable standard experimental procedures. In the
present study six indigenous anticancer medicinal plants
(I. spinosa, N. glauca, T. apollinea, T. nilotica, C. hartman-
nianum and C. decidua) from Sudan were studied. Since
the people of Sudan have long been using these plants as
either food or medicine, the plants considered as an inte-
gral part of the local pharmacopoeia. In the present study,
different parts of the plants were selected to prepare 32
extracts using sequential extraction method with 4 sol-
vents of different polarity. The rationale for performing
extractions from non-polar to polar solvents is to confirm
and validate the bio-efficacy in the aqueous extractions
performed in the traditional manner in the form of tonics
and aqueous pastes. In addition, the extracts with different
polarities provide an idea about the specific phytochemical
groups of the active principles present in the extracts.
This study aimed to evaluate the anti-carcinogenic activ-
ities of the 6 Sudanese medicinal plants and to correlate
these activities with phytochemical analysis and antioxi-
dant capability. Two assays were used to assess the anti-
carcinogenic properties of the plant extracts. One is the
MTT assay which provides a simple method for determin-
ation of cell’s viability via mitochondrial activity in living
cells and other one is the rat aorta ring assay, which is
based on the ability of the aortic wall to produce neo-
vessels in bio-matrix gels after mechanical injury or angio-
genic factor stimulation.
The results of rat aortic ring assay showed that, out of 6
tested plants,T. apollinea, C. hartmannianum and T. nilo-
tica showed strong inhibitory effect (more than 60%). Par-
ticularly, the ethanol extract of aerial parts of T. apollinea
demonstrated highest anti-angiogenic activity by inhibiting
100% of the aortic microvessels. Noteworthily, all the ex-
tracts of C. hartmannianum displayed significant anti-
angiogenic activity.
Whereas, results of the cytotoxic assay showed that
among all the extracts, the highly non-polar solvent ex-
tract i.e., hexane extract demonstrated higher cytotoxic ac-
tivity than the other solvent extracts. Among the 6 plants,
the hexane extracts of N. glauca leaves and stem bark ex-
hibited most potent anti-proliferative effect on all the tested
cancer cell lines. However, for the plant T. apollinea, both
non-polar (hexane) and polar (ethanol) extracts displayed
selective cytotoxicity towards hormone dependent breast
cancer cell line (MCF-7). Consistently, again the extracts of
C. hartmannianum leaves and stem bark exhibited stronginhibitory effect against the proliferation of HCT-116 and
MCF-7 cells. Noteworthily, the extracts of the most effect-
ive plants (N. glauca, T. apollinea and C. hartmannianum)
did not produce significant cytotoxic effects against the
normal cell lines (HUVEC and CCD-18Co).
Altogether, the most biologically active plants which
showed significant antiangiogenic as well as cytotoxic
activities were N. glauca, T. apollinea, C. hartmannia-
num and T. nilotica. These findings were further sup-
ported by the results of DPPH scavenging activity. The
results showed that, most of the extracts of C. hartman-
nianum displayed strong DPPH quenching ability with
lowest IC50 (9 μg/ml), which was followed by N. glauca,
T. nilotica and T. apollinea (Table 5).
The antiangiogenic and anti-proliferative effects of the
plants may be due to their potential antioxidant activity,
which further attributes to the collective contribution of
phenolics and flavonoids present it the respective extracts.
The findings of the present study revealed that these
plants are enriched with phenolic and flavonoid contents
than compared to the other plants which have shown less
bio-efficacy. On average, the plants N. glauca,T. apollinea,
C. hartmannianum and T. nilotica exhibited high antioxi-
dant activity in DPPH free radical scavenging assay. This
may support the traditional usage of these plants to im-
prove complications such oxidative stress in cancer and
other diseases. Many health beneficial effects of flavonoids
are attributed to their ability to act as antioxidants. Re-
search studies have shown that flavonoids as single elec-
tron donors can stabilize and scavenge the free radicals,
which in conditions of oxidative stress may initiate angio-
genesis or carcinogenesis. Similarly, phenolics have strong
capability to interfere in a series of physiological events in
biological systems, including those relating to oxidation
processes [29].
Phenolics and flavonoids mostly found in plants are
reported to have numerous biological effects including
antioxidant, anti-neovascularization, antiproliferation
and anticarcinogenic properties and are therefore consid-
ered for their important dietary roles as antioxidants and
chemoprotective agents. Recently, intensive research has
been focused on studying the naturally occurring pheno-
lics and flavonoids that are able to decrease the generation
of reactive oxygen species (ROS) in biological system. Oxi-
dative stress contributed by ROS plays a critical role in the
pathologies related with chronic disease such as cancer
and excessive vascularization [30]. ROS-induced develop-
ment of cancer involves malignant transformation due to
DNA mutations and altered gene expression through epi-
genetic mechanisms which in turn leads to the uncon-
trolled proliferation of cancerous cells. Further, high levels
of ROS are observed in various cancerous cells and a
number of accumulating evidences [31-33] suggest that
ROS function as key signaling molecules to stimulate
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angiogenesis and tumorigenesis [27]. Several studies
demonstrated a significant role of phenolics in growth
inhibition of breast, colon, prostate, ovary, endometrium
and lung cancer cells [34,35].
The present study confirmed that the extracts of
N. glauca, T. apollinea and C. hartmannianum demon-
strated selective cytotoxicity towards human breast and
colon cancer cell lines while being less cytotoxic against
the normal cells. Such selective cytotoxic activity sug-
gested that the active substances interact with special
cancer-associated receptors or cancer cell special mol-
ecule, thus triggering some mechanisms that cause
cancer cell death [36]. In observation under EVOS f1
digital microscope, typical apoptotic characteristics
were observed, including cell membrane blebbing, loss
of pseudopodia-like cellular projections, nuclear con-
densation, and separated apoptotic bodies (Figure 3). In
addition, the treated MCF-7 cells displayed typical signs
of apoptosis such as shrinkage of cells, chromatin conden-
sation and crescent shaped nuclei (Figure 3, MCF-7 row).
Several reports have revealed that flavonoids are able to
inhibit the growth of cancer cells in vitro [37-39]. These
findings are confirmed by several in vivo studies [40].
Flavonoids exert their anticancer action through affect-
ing key mechanisms involved in cancer pathogenesis.
Flavonoids are effective antioxidant and antiangiogenic
agents. In initial stages, they inhibit metabolic activation
of carcinogens. In progression phases they induce apop-
tosis, inhibit angiogenesis, cancer cell proliferation and
tumor metastasis [41].
The magnitude of phenolic compounds in redox system
acts either as reducing agents, hydrogen donators, singlet
oxygen quenchers or in some cases as a metal chelating
agents [42] thereby, the free radicals which generated in the
metabolic pathways could be neutralized by phenolic com-
pounds [43]. From the results obtained in this study, there
is an obvious correlation between antiangiogenic and anti-
oxidant activity, since the polyphenols inhibit the initiation
and progression of angiogenesis [44-46]. Therefore, plant
polyphenols may play an important role in halting angio-
genesis, as well as have ability to prevent oxidant potentials
of free radicals as natural source of antioxidants.
Results of the present study were completely in agree-
ment with the study reported by Mariod et al., [47] on the
various extracts of C. hartmannianum for its antioxidant
property and total phenolic content. In the present study,
C. hartmannianum demonstrated strong antiproliferative
and antiangiogenic activities. It is reported that C. hartman-
nianum has strong capability to inhibit tyrosine kinase [48].
Tyrosine kinase is an important cellular signaling protein
which has essential and critical role in several biological ac-
tivities including cell proliferation and angiogenesis [49].
Several tyrosine kinase inhibitors such as, bevacizumab,sunitinib, sorafenib and pazopanib were recently approved
for treatment of patients with malignant carcinoma [50,51].
In addition, many other anti-angiogenic tyrosine kinase
inhibitors are being studied in phase I-III clinical trials in
order to validate their beneficial anti-tumor, anti-metastatic
and anti-angiogenic activities in human beings [52].
In this study, another herb that has shown a promising
cytotoxicity on the tested cancer cell lines was N. glauca.
Ibrahim and El-Sharkawy [53] reported the antioxidant
activity and presence of phenolics and flavonoids in the
leaves of N. glauca however, the present study reported
that even stem bark extracts of the plant has remarkable
antioxidant activity which could be attributed to the
presence of high levels of phenolics and flavonoids in it.
The present study showed that both non-polar and polar
extracts of aerial part of T. apollinea (Figure 3) exhibited
selective antiproliferative effect against breast cancer cell
line MCF-7. However, in our previous study [54] we re-
ported the isolation of (−)-pseudosemiglabrin from aerial
parts of T. apollinea and its antiproliferative activity on
prostate, leukemia, breast and colon cancer cells. In the
present study, the anticancer and antiangiogenic activities
of nonpolar (hexane) extracts could be partly attributed to
the high levels of flavonoid. It is well known that the
plant-flavonoids demonstrated promising anticancer and
antiangiogenic activities [55]. Several studies [56] reported
the presence of complex prenylated flavones and phenolic
compounds in T. apollinea and thus the antiangiogenic
and antiproliferative properties of the herb recorded in the
present study can be attributed to the cumulative effects
of such bioactive constituents.
For the first time the present study reported the cyto-
toxic potentials of leaves of T. nilotica against human colon
(HCT-116) and breast (MCF-7) cancer cells. However, the
earlier reports mentioned that T. nilotica has selective
cytotoxic potential against liver cell carcinoma (Huh-7),
while being non-toxic to other cancer cells [57]. Neverthe-
less, the results of the present study agree in part with the
previous findings [57] in the sense that T. nilotica has
noticeable DPPH quenching capability. These findings are
in agreement with some earlier reports [58,59] wherein,
various types of phenolic constituents such as phenolic
glyceride, phenolic lactone, phenolic aldehydes and dimeric
phenols were isolated from the of T. nilotica.
Anti-angiogenic agent could target the cancer or endo-
thelial cells at any of the steps necessary for carcinogenesis
or neovascularization, such as proliferation, differentiation,
migration, or tube formation [60]. Angiogenesis inhibitors
act by actively promoting apoptosis in cells. In vitro and
in vivo investigations have proved that many endogenous
antiangiogenic compounds induce cytotoxicity via apop-
totic cellular death [61].
The results of the present study could be very helpful
as preliminary data in the search for new antitumor
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cinal plants. These plants have the potential to be che-
mically standardized and used as herbal medicines or
developed into pharmaceutical drugs for the treatment of
angiogenesis-dependent human ailments such as cancer
and other hyperproliferative disorders. Bioassay-guided
phytochemical and pharmacological studies are under
investigation in an attempt to isolate and characterize
the active constituents from the extracts of the plants
which have shown promising antiangiogenic and
anticancer properties.
Conclusion
In conclusion the present study revealed that among the six
Sudanese medicinal plants tested, N. glauca, T. apollinea,
C. hartmannianum and T. nilotica found to be most
biologically effective herbs with significant antiangiogenic
and antineoplastic effects. The biological activities observed
in the study could be attributed to the antioxidant and
higher phenolic and flavonoid contents of the plants.
Furthermore, the extracts of these plants displayed either
negligible or insignificant cytotoxicity against the tested
human normal cells. Thus, these herbs could be considered
as promising candidates for the development of novel
chemopreventive or chemotherapeutic formulations with
reduced side effects. The results obtained in the present
study justify the traditional use of these medicinal plants
to cure neoplasia. However, further studies to isolate the
active compounds and to investigate the mode of action
using in vivo xenograft experimental models are war-
ranted against pathological neovascularization and tumor
malignancy.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AMSAM, MBKA, and LEAH designed the experiments. LEAH, HB and NSM
carried out the phytochemical analysis. LEAH, NSM and ZDN performed the
ex vivo antiangiogenic activity. LEAH, ZGN and HB participated in cytotoxic
study on the plants. LEAH, MBKA, ASAM and AMSAM analyzed the data and
interpreted the results. LEAH, MBKA and ASAM drafted the manuscript.
All the authors read and approved the final manuscript.Acknowledgments
We wish to acknowledge TWAS-USM (FR number: 3240240313) for the fellowship
to LEAH and financial support for this research. In addition, the authors wish to
acknowledge the support from Universiti Sains Malaysia for the research study
through Research University Team (RUT) Grant No.: 1001/PFARMASI/851001.
Author details
1EMAN Research and Testing Laboratory, School of Pharmaceutical Sciences,
Universiti Sains Malaysia, Penang, Malaysia. 2Department of Botany, Faculty of
Science& Technology, Omdurman Islamic University, P.O. Box 383,
Omdurman, Sudan. 3Advanced Medical and Dental Institute (IPPT), Universiti
Sains Malaysia, Penang, Malaysia. 4Department of Pharmacy, College of
medicine and Health Sciences, Hadhramout University, Fuluk, Mukalla,
Hadhramout, Republic of Yemen. 5School of Pharmacy, The University of
Queensland, 20 Cornwall Street, Woolloongabba, QLD 4102, Australia.Received: 23 July 2014 Accepted: 10 October 2014
Published: 20 October 2014References
1. Bray F, Ren JS, Masuyer E, Ferlay J: Global estimates of cancer prevalence
for 27 sites in the adult population in 2008. Int J Cancer 2013,
132(5):1133–1145.
2. Chorawala MR, Oza PM, Shah GB: Mechanisms of anticancer drugs
resistance: an overview. Int J Pharma Sci Drug Res 2012, 1:01–09.
3. Cragg GM, Newman DJ: Plants as a source of anti-cancer agents.
J Ethnopharmacol 2005, 100(1–2):72–79.
4. Jung Park E, Pezzuto J: Botanicals in cancer chemoprevention.
Cancer Metastasis Rev 2002, 21(3–4):231–255.
5. Shoeb M: Anticancer Agents from Medicinal Plants. Pharmacology:
Bangladesh Journal of; 2006:1(2006).
6. Newman DJ, Cragg GM: Natural products as sources of new drugs over
the 30 years from 1981 to 2010. J Nat Prod 2012, 75(3):311–335.
7. Jaspars M, Lawton LA: Cyanobacteria - a novel source of pharmaceuticals.
Curr Opin Drug Discov Devel 1998, 1(1):77–84.
8. Folkman J: What is the evidence that tumors are angiogenesis
dependent? J Natl Cancer Inst 1990, 82(1):4–6.
9. Folkman J: Role of angiogenesis in tumor growth and metastasis.
Semin Oncol 2002, 29(6, Supplement 16):15–18.
10. Scappaticci FA: The therapeutic potential of novel antiangiogenic
therapies. Expert Opin Investig Drugs 2003, 12(6):923–932.
11. Dell’Eva R, Pfeffer U, Vené R, Anfosso L, Forlani A, Albini A, Efferth T:
Inhibition of angiogenesis in vivo and growth of Kaposi’s sarcoma
xenograft tumors by the anti-malarial artesunate. Biochem Pharmacol
2004, 68(12):2359–2366.
12. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W,
Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R,
Kabbinavar F: Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin
for Metastatic Colorectal Cancer. N Engl J Med 2004, 350(23):2335–2342.
13. Al-Suede FSR, Farsi E, Ahamed MKB, Ismail Z, Abdul Majid AS, Abdul Majid
AMS: Marked antitumor activity of cat’s whiskers tea (Orthosiphon
stamineus) extract in orthotopic model of human colon tumor in nude
mice. J Biochem Tech 2012, 5(28 December 2012):S170–S176.
14. Dawidowicz AL, Wianowska D, Baraniak B: The antioxidant properties of
alcoholic extracts from Sambucus nigra L. (antioxidant properties of
extracts). LWT Food Sci Technol 2006, 39(3):308–315.
15. Yoysungnoen P, Wirachwong P, Changtam C, Suksamrarn A, Patumraj S:
Anti-cancer and anti-angiogenic effects of curcumin and tetrahydrocurcumin
on implanted hepatocellular carcinoma in nude mice. World J Gastroenterol
2008, 14(13):2003–2009.
16. Munzel T, Gori T, Bruno RM, Taddei S: Is oxidative stress a therapeutic
target in cardiovascular disease? Eur Heart J 2010, 31(22):2741–2748.
17. Dell’Agli M, Buscialà A, Bosisio E: Vascular effects of wine polyphenols.
Cardiovasc Res 2004, 63(4):593–602.
18. Galal M, Bashir AK, Salih AM, Adam SL: Activity of water extracts of Albizia
Anthelmintica and A. lebek barks against experimenta Hymenolepis
diminuta infection in rats. J Ethnopharmacol 1991, 33(1991):333–337.
19. Eatock MM, Schatzlein A, Kaye SB: Tumour vasculature as a target for
anticancer therapy. Cancer Treat Rev 2000, 26(3):191–204.
20. Al-Salahi OSA, Kit-Lam C, Majid AM, Al-Suede FS, Mohammed Saghir SA,
Abdullah WZ, Ahamed MB, Yusoff NM: Anti-angiogenic quassinoid-rich
fraction from Eurycoma longifolia modulates endothelial cell function.
Microvasc Res 2013, 90:30–39.
21. Ahamed MB, Aisha AF, Nassar ZD, Siddiqui JM, Ismail Z, Omari SM, Parish CR,
Majid AM: Cat’s whiskers tea (Orthosiphon stamineus) extract inhibits
growth of colon tumor in nude mice and angiogenesis in endothelial cells
via suppressing VEGFR phosphorylation. Nutr Cancer 2012, 64(1):89–99.
22. Al-Suede FSR, Khadeer Ahamed MB, Abdul Majid AS, Baharetha HM, Hassan LE,
Kadir MOA, Nassar ZD, Abdul Majid AMS: Optimization of cat’s whiskers tea
(orthosiphon stamineus) using supercritical carbon dioxide and selective
chemotherapeutic potential against prostate cancer cells. Evid Based
Complement Alternat Med 2014, 2014:15.
23. Baharetha HM, Nassar ZD, Aisha AF, Khadeer AMB, Al-Suede FSR, Abd KMO,
Zhari I, Abdul MAMS: Proapoptotic and antimetastatic properties of
supercritical CO2 extract of Nigella sativa Linn. against breast cancer
cells. J Med Food 2013, 16(12):1121–1130.
Hassan et al. BMC Complementary and Alternative Medicine 2014, 14:406 Page 14 of 14
http://www.biomedcentral.com/1472-6882/14/40624. Khadeer Ahamed MB, Krishna V, Dandin CJ: In vitro antioxidant and in vivo
prophylactic effects of two gamma-lactones isolated from Grewia
tiliaefolia against hepatotoxicity in carbon tetrachloride intoxicated rats.
Eur J Pharmacol 2010, 631(1–3):42–52.
25. Gibellini L, Pinti M, Nasi M, De Biasi S, Roat E, Bertoncelli L, Cossarizza A:
Interfering with ROS metabolism in cancer cells: the potential role of
quercetin. Cancer 2010, 2(14 June 2010):1288–1311.
26. Coso S, Harrison I, Harrison CB, Vinh A, Sobey CG, Drummond GR, Williams ED,
Selemidis S: NADPH oxidases as regulators of tumor angiogenesis: current
and emerging concepts. Antioxid Redox Signal 2012, 16(11):1229–1247.
27. Ushio-Fukai M, Nakamura Y: Reactive oxygen species and angiogenesis:
NADPH oxidase as target for cancer therapy. Cancer Lett 2008, 266(1):37–52.
28. Hilmi Y, Abushama MF, Abdalgadir H, Khalid A, Khalid H: A study of
antioxidant activity, enzymatic inhibition and in vitro toxicity of selected
traditional sudanese plants with anti-diabetic potential. BMC Complement
Altern Med 2014, 14(1):1472–6882.
29. Balasundram N, Sundram K, Samman S: Phenolic compounds in plants
and agri-industrial by-products: antioxidant activity, occurrence, and
potential uses. Food Chem 2006, 99(1):191–203.
30. Kampa M, Nifli AP, Notas G, Castanas E: Polyphenols and cancer cell
growth. Rev Physiol Biochem Pharmacol 2007, 159:79–113.
31. Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T, Kuroiwa Y:
Stimulation of in vitro angiogenesis by hydrogen peroxide and the
relation with ETS-1 in endothelial cells. Life Sci 1999, 64(4):249–258.
32. Yeldandi AV, Rao MS, Reddy JK: Hydrogen peroxide generation in
peroxisome proliferator-induced oncogenesis. Mutat Res 2000,
448(2):159–177.
33. Irani K, Xia Y, Zweier JL, Sollott SJ, Der CJ, Fearon ER, Sundaresan M, Finkel T,
Goldschmidt-Clermont PJ: Mitogenic signaling mediated by oxidants in
Ras-transformed fibroblasts. Science 1997, 275(5306):1649–1652.
34. Galati G, O’Brien PJ: Potential toxicity of flavonoids and other dietary
phenolics: significance for their chemopreventive and anticancer
properties. Free Radic Biol Med 2004, 37(3):287–303.
35. Baghel SS, Shrivastava N, RS Baghel PA, Rajput S: A review of quercetin:
antioxidant and anticancer properties. World J Pharm Pharmaceutical Sci
2012, 1(1):146–160.
36. Harada H, Noro T, Kamei Y: Selective antitumor activity in vitro from
marine algae from Japan coasts. Biol Pharm Bull 1997, 20(5):541–546.
37. Moghaddam G, Ebrahimi SA, Rahbar-Roshandel N, Foroumadi A: Antiproliferative
activity of flavonoids: influence of the sequential methoxylation state of the
flavonoid structure. Phytother Res 2012, 26(7):1023–1028.
38. Delmulle L, Bellahcène A, Dhooge W, Comhaire F, Roelens F, Huvaere K,
Heyerick A, Castronovo V, De Keukeleire D: Anti-proliferative properties of
prenylated flavonoids from hops (Humulus lupulus L.) in human
prostate cancer cell lines. Phytomedicine 2006, 13(9–10):732–734.
39. Chidambara Murthy KN, Kim J, Vikram A, Patil BS: Differential inhibition of
human colon cancer cells by structurally similar flavonoids of citrus.
Food Chem 2012, 132(1):27–34.
40. Batra P, Sharma A: Anti-cancer potential of flavonoids: recent trends and
future perspectives. 3 Biotech 2013, 3(6):439–459.
41. Clere N, Faure S, Martinez MC, Andriantsitohaina R: Anticancer properties
of flavonoids: roles in various stages of carcinogenesis.
Cardiovasc Hematol Agents Med Chem 2011, 9(2):62–77.
42. Gordon MH: The Mechanism of Antioxidant Action in Vitro. In Food
Antioxidants. Edited by Hudson BJF. Netherlands: Springer; 1990:1–18.
43. Miliauskas G, Venskutonis PR, van Beek TA: Screening of radical scavenging
activity of some medicinal and aromatic plant extracts. Food Chem 2004,
85(2):231–237.
44. Stoclet J-C, Chataigneau T, Ndiaye M, Oak MH, El Bedoui J, Chataigneau M,
Schini-Kerth VB: Vascular protection by dietary polyphenols. Eur J Pharmacol
2004, 500(1–3):299–313.
45. Oak MH, El Bedoui J, Schini-Kerth VB: Antiangiogenic properties of natural
polyphenols from red wine and green tea. J Nutr Biochem 2005, 16(1):1–8.
46. Walter A, Etienne-Selloum N, Brasse D, Schleiffer R, Bekaert V, Vanhoutte PM,
Beretz A, Schini-Kerth VB: Red wine polyphenols prevent acceleration of
neovascularization by angiotensin II in the ischemic rat hindlimb.
J Pharmacol Exp Ther 2009, 329(no. 2):329–699.
47. Mariod A, Matthäus B, Hussein IH: Antioxidant activities of extracts from
Combretum hartmannianum and Guiera senegalensis on the oxidative
stability of sunflower oil. Emir J Food Agric 2006, 18(2006):20–28.48. Ali H, König GM, Khalid SA, Wright AD, Kaminsky R: Evaluation of selected
Sudanese medicinal plants for their in vitro activity against
hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory,
and for cytotoxicity. J Ethnopharmacol 2002, 83(3):219–228.
49. Gotink KJ, Verheul HM: Anti-angiogenic tyrosine kinase inhibitors: what is
their mechanism of action? Angiogenesis 2010, 13(1):1–14.
50. Faivre S, Demetri G, Sargent W, Raymond E: Molecular basis for sunitinib
efficacy and future clinical development. Nat Rev Drug Discov 2007,
6(9):734–745.
51. Wilhelm S, Carter C, Lynch M, Lowinger T, Dumas J, Smith RA, Schwartz B,
Simantov R, Kelley S: Discovery and development of sorafenib: a
multikinase inhibitor for treating cancer. Nat Rev Drug Discov 2006,
5(10):835–844.
52. Patel PH, Chaganti RS, Motzer RJ: Targeted therapy for metastatic renal
cell carcinoma. Br J Cancer 2006, 94(5):614–619.
53. Ibrahim B, A.E.-S, Saleh H: Phytochemical Investigation of Nicotiana glauca
and Microbial Degradation of Nicotine as a Water Pollutant of Tobacco.
Fairford, GLO, United Kingdom: LAP LAMBERT Academic Publishing; 2012.
54. Hassan LEA, M.B.K.A, Majid ASA, Iqbal MA, Al Suede FSR, Haque RA, Ismail Z,
Ein OC, Majid AMSA: Crystal structure elucidation and anticancer studies
of (−)-pseudosemiglabrin: a flavanone isolated from the aerial parts of
tephrosia apollinea. PLoS ONE 2014, 9(3):90806.
55. Dai Z-J, Lu WF, Gao J, Kang HF, Ma YG, Zhang SQ, Diao Y, Lin S, Xi-Jing W,
Wu WY: Anti-angiogenic effect of the total flavonoids in Scutellaria
barbata D. Don. BMC Complement Altern Med 2013, 13(1):1–10.
56. Abou-Douh AM, I.C, Toscano RA, Nariman N, El-Khrisy E: Prenylated flavonoids
from the root of Egyptian Tephrosia apollinea–crystal structure analysis.
Z Naturforsch 2005, B 60:458–470.
57. Abouzid S, Sleem A: Hepatoprotective and antioxidant activities of
Tamarix nilotica flowers. Pharm Biol 2011, 49(4):392–395.
58. Nawwar MAM, Buddrus J, Bauer H: Dimeric phenolic constituents from the
roots of Tamarix nilotica. Phytochemistry 1982, 21(7):1755–1758.
59. Barakat HH, Nawwar MA, Buddrus J, Linscheid M: Niloticol, a phenolic
glyceride and two phenolic aldehydes from the roots of Tamarix nilotica.
Phytochemistry 1987, 26(6):1837–1838.
60. Folkman J: Angiogenesis and apoptosis. Semin Cancer Biol 2003, 13(2):159–167.
61. Tiwari M: Apoptosis, angiogenesis and cancer therapies. J Cancer Ther Res
2012, 1(1):3.
doi:10.1186/1472-6882-14-406
Cite this article as: Hassan et al.: Correlation of antiangiogenic,
antioxidant and cytotoxic activities of some Sudanese medicinal plants
with phenolic and flavonoid contents. BMC Complementary and
Alternative Medicine 2014 14:406.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
